257 related articles for article (PubMed ID: 17452975)
1. Loss of suppressor-of-fused function promotes tumorigenesis.
Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
[TBL] [Abstract][Full Text] [Related]
2. Patched2 modulates tumorigenesis in patched1 heterozygous mice.
Lee Y; Miller HL; Russell HR; Boyd K; Curran T; McKinnon PJ
Cancer Res; 2006 Jul; 66(14):6964-71. PubMed ID: 16849540
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.
Svärd J; Rozell B; Toftgård R; Teglund S
Mol Carcinog; 2009 May; 48(5):408-19. PubMed ID: 18781608
[TBL] [Abstract][Full Text] [Related]
4. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
[TBL] [Abstract][Full Text] [Related]
5. Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2.
Shakhova O; Leung C; van Montfort E; Berns A; Marino S
Cancer Res; 2006 May; 66(10):5190-200. PubMed ID: 16707443
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.
Sasai K; Romer JT; Kimura H; Eberhart DE; Rice DS; Curran T
Cancer Res; 2007 Apr; 67(8):3871-7. PubMed ID: 17413002
[TBL] [Abstract][Full Text] [Related]
7. Mutations in SUFU predispose to medulloblastoma.
Taylor MD; Liu L; Raffel C; Hui CC; Mainprize TG; Zhang X; Agatep R; Chiappa S; Gao L; Lowrance A; Hao A; Goldstein AM; Stavrou T; Scherer SW; Dura WT; Wainwright B; Squire JA; Rutka JT; Hogg D
Nat Genet; 2002 Jul; 31(3):306-10. PubMed ID: 12068298
[TBL] [Abstract][Full Text] [Related]
8. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Kool M; Jones DT; Jäger N; Northcott PA; Pugh TJ; Hovestadt V; Piro RM; Esparza LA; Markant SL; Remke M; Milde T; Bourdeaut F; Ryzhova M; Sturm D; Pfaff E; Stark S; Hutter S; Seker-Cin H; Johann P; Bender S; Schmidt C; Rausch T; Shih D; Reimand J; Sieber L; Wittmann A; Linke L; Witt H; Weber UD; Zapatka M; König R; Beroukhim R; Bergthold G; van Sluis P; Volckmann R; Koster J; Versteeg R; Schmidt S; Wolf S; Lawerenz C; Bartholomae CC; von Kalle C; Unterberg A; Herold-Mende C; Hofer S; Kulozik AE; von Deimling A; Scheurlen W; Felsberg J; Reifenberger G; Hasselblatt M; Crawford JR; Grant GA; Jabado N; Perry A; Cowdrey C; Croul S; Zadeh G; Korbel JO; Doz F; Delattre O; Bader GD; McCabe MG; Collins VP; Kieran MW; Cho YJ; Pomeroy SL; Witt O; Brors B; Taylor MD; Schüller U; Korshunov A; Eils R; Wechsler-Reya RJ; Lichter P; Pfister SM;
Cancer Cell; 2014 Mar; 25(3):393-405. PubMed ID: 24651015
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of Fused Plays an Important Role in Regulating Mesodermal Differentiation of Murine Embryonic Stem Cells In Vivo.
Hoelzl MA; Heby-Henricson K; Bilousova G; Rozell B; Kuiper RV; Kasper M; Toftgård R; Teglund S
Stem Cells Dev; 2015 Nov; 24(21):2547-60. PubMed ID: 26176320
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway.
Yue S; Chen Y; Cheng SY
Oncogene; 2009 Jan; 28(4):492-9. PubMed ID: 18997815
[TBL] [Abstract][Full Text] [Related]
11. Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.
Yin WC; Satkunendran T; Mo R; Morrissy S; Zhang X; Huang ES; Uusküla-Reimand L; Hou H; Son JE; Liu W; Liu YC; Zhang J; Parker J; Wang X; Farooq H; Selvadurai H; Chen X; Ngan ES; Cheng SY; Dirks PB; Angers S; Wilson MD; Taylor MD; Hui CC
Dev Cell; 2019 Jan; 48(2):167-183.e5. PubMed ID: 30554998
[TBL] [Abstract][Full Text] [Related]
12. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
[TBL] [Abstract][Full Text] [Related]
14. Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development.
Zhulyn O; Nieuwenhuis E; Liu YC; Angers S; Hui CC
Dev Biol; 2015 Jan; 397(2):191-202. PubMed ID: 25448692
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
Zindy F; Uziel T; Ayrault O; Calabrese C; Valentine M; Rehg JE; Gilbertson RJ; Sherr CJ; Roussel MF
Cancer Res; 2007 Mar; 67(6):2676-84. PubMed ID: 17363588
[TBL] [Abstract][Full Text] [Related]
16. Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice.
Heby-Henricson K; Bergström A; Rozell B; Toftgård R; Teglund S
Mol Carcinog; 2012 Sep; 51(9):754-60. PubMed ID: 21882258
[TBL] [Abstract][Full Text] [Related]
17. Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused.
Cooper AF; Yu KP; Brueckner M; Brailey LL; Johnson L; McGrath JM; Bale AE
Development; 2005 Oct; 132(19):4407-17. PubMed ID: 16155214
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.
Tostar U; Malm CJ; Meis-Kindblom JM; Kindblom LG; Toftgård R; Undén AB
J Pathol; 2006 Jan; 208(1):17-25. PubMed ID: 16294371
[TBL] [Abstract][Full Text] [Related]
19. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
[TBL] [Abstract][Full Text] [Related]
20. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies.
Sasai K; Romer JT; Lee Y; Finkelstein D; Fuller C; McKinnon PJ; Curran T
Cancer Res; 2006 Apr; 66(8):4215-22. PubMed ID: 16618744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
